Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis
- 1 January 2000
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 43 (1), 195-205
- https://doi.org/10.1002/1529-0131(200001)43:1<195::aid-anr24>3.0.co;2-g
Abstract
Objective To correlate the increased collagenase production previously seen in chondrocytes isolated from osteoarthritic (OA) lesions and the expression of cytokines and cytokine receptors. Methods Chondrocytes were isolated from OA cartilage and characterized for synthesis of collagenases, cytokines, and cytokine receptors by Northern and Western blot analyses, RNA protection assay, and flow cytometry. Results Chondrocytes located in cartilage proximal to the macroscopic OA lesions bound more tumor necrosis factor α (TNFα) and interleukin‐1β (IL‐1β) compared with chondrocytes isolated from morphologically normal cartilage from the same joint. In response to TNFα stimulation, messenger RNA (mRNA) levels for the IL‐1 receptor I (IL‐1RI), IL‐1RII, TNF receptor II (TNFR II), and IL‐6 receptor as well as the level of proinflammatory cytokines, such as IL‐1α, IL‐1β, lymphotoxin β, TNFα, and IL‐6, also increased. In contrast, treatment with transforming growth factor β1 (TGFβ1) resulted in down‐regulation of matrix metalloproteinase 1 (MMP‐1) and MMP‐13 concomitant with a reduction in the levels of mRNA for IL‐1RI, IL‐1RII, TNFRI, and TNFRII and proinflammatory cytokine levels. In contrast, the levels of mRNA for TGFβ receptor I, TGFβ1, and TGFβ3 were up‐regulated. Conclusion These data show that TGFβ1 has antagonistic effects upon OA chondrocytes, in contrast to the effects seen with TNFα. The cyclical course of OA, where a period of active disease is followed by a period of remission, can be explained by a sequential pattern of cytokine stimulation followed by a feedback inhibition of autocrine cytokine production and cytokine receptor expression, thus affecting collagenase synthesis.Keywords
This publication has 28 references indexed in Scilit:
- Osteoarthritic synovial fluid and synovium supernatants up-regulate tumor necrosis factor receptors on human articular chondrocytesOsteoarthritis and Cartilage, 1998
- Osteoarthritic Lesions. Involvement of three different collagenasesArthritis & Rheumatism, 1997
- The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis.Journal of Clinical Investigation, 1996
- Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling.The Journal of Experimental Medicine, 1996
- Tumor necrosis factor-α (TNF-α) in canine osteoarthritis: Immunolocalization of TNF-α, stromelysin and TNF receptors in canine osteoarthritic cartilageOsteoarthritis and Cartilage, 1996
- Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.Journal of Clinical Investigation, 1996
- Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts.Journal of Clinical Investigation, 1994
- Transforming growth factor β exerts opposite effects from interleukin‐1β on cultured rabbit articular chondrocytes through reduction of interleukin‐1 receptor expressionArthritis & Rheumatism, 1993
- The interleukin‐1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic functionArthritis & Rheumatism, 1992
- Platelet‐derived growth factor potentiates cellular responses of articular chondrocytes to interleukin‐1Arthritis & Rheumatism, 1991